ANKRD40 Knockout HEK293T Polyclonal Cells offer a CRISPR/Cas9-edited polyclonal knockout cell population derived from HEK293T cells, with targeted disruption of the ANKRD40 gene. This loss-of-function model enables systematic investigation of ANKRD40’s biological functions without assumptions of monoclonality, ensuring representation of multiple knockout alleles across the cell pool. The polyclonal format minimizes clonal artifacts and provides a robust platform for studying gene function in a heterogeneous, population-level context. Researchers can interrogate the consequences of ANKRD40 ablation in a physiologically relevant cellular background, leveraging the inherent advantages of polyclonal editing for broad applicability in functional genomics.
HEK293T cells are an immortalized human embryonic kidney line that stably expresses the SV40 large T antigen. This feature permits episomal replication of transfected plasmids containing the SV40 origin, resulting in elevated protein expression from transiently introduced vectors. The cell line is renowned for its exceptional transfection efficiency and rapid growth kinetics, making it a workhorse for recombinant protein production, lentiviral packaging, and high-throughput screening. Its embryonic kidney origin provides a versatile cellular context for studying basic cellular processes, signaling pathways, and disease-relevant mechanisms, including those related to cancer biology.
ANKRD40 encodes a putative scaffold protein characterized by ankyrin repeat domains, which are evolutionarily conserved motifs known to mediate protein-protein interactions. While its precise molecular function remains under active investigation, ANKRD40 is predicted to facilitate the assembly of multiprotein complexes, thereby organizing signaling networks and cellular architectures. Upstream regulators, downstream effectors, and direct interaction partners of ANKRD40 have not yet been identified, limiting mechanistic understanding. However, expression profiling hints at possible relevance to cancer, positioning ANKRD40 as an emerging candidate for functional exploration in oncogenic signaling. Its disruption is hypothesized to perturb protein interaction hubs, offering a tractable model for dissecting scaffolding roles in cellular homeostasis.
Within the HEK293T cellular background, ANKRD40 knockout provides a defined system to interrogate its contributions to cellular physiology. The high transfection efficiency of HEK293T cells facilitates rescue experiments and overexpression of tagged variants, enabling structure-function analyses of the ankyrin repeat domains. The polyclonal knockout population maintains genetic diversity at the targeted locus, which can reveal consistent phenotypic outcomes despite heterogeneous editing events. This model is particularly suited for mapping protein interaction networks via co-immunoprecipitation and mass spectrometry, as well as for assessing global changes in protein stability, cell cycle progression, and apoptotic responses upon loss of ANKRD40.
Key applications of this knockout product include functional characterization of ANKRD40, identification of binding partners through affinity purification coupled with mass spectrometry, and investigation of ANKRD40-mediated effects on cell proliferation and survival using Western blotting and flow cytometry-based assays. The cells are compatible with high-content screening to monitor pathway perturbation and can serve as a negative control for subsequent interaction studies. By enabling the dissection of ANKRD40-dependent processes, this model accelerates the discovery of its roles in signaling and disease. For additional technical specifications or assistance with experimental design, please contact Ascent Research.
